BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23209384)

  • 1. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis.
    Winetsky DE; Negoescu DM; DeMarchis EH; Almukhamedova O; Dooronbekova A; Pulatov D; Vezhnina N; Owens DK; Goldhaber-Fiebert JD
    PLoS Med; 2012; 9(11):e1001348. PubMed ID: 23209384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
    Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
    PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.
    Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S
    BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria.
    Ugwu KO; Onah IS; Mbah GC; Ezeonu IM
    J Infect Dev Ctries; 2020 Sep; 14(9):1011-1018. PubMed ID: 33031090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.
    Drobniewski F; Cooke M; Jordan J; Casali N; Mugwagwa T; Broda A; Townsend C; Sivaramakrishnan A; Green N; Jit M; Lipman M; Lord J; White PJ; Abubakar I
    Health Technol Assess; 2015 May; 19(34):1-188, vii-viii. PubMed ID: 25952553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China.
    Ou X; Xia H; Li Q; Pang Y; Wang S; Zhao B; Song Y; Zhou Y; Zheng Y; Zhang Z; Zhang Z; Li J; Dong H; Chi J; Zhang J; Kam KM; Huan S; Jun Y; Chin DP; Zhao Y
    Int J Infect Dis; 2015 Feb; 31():41-6. PubMed ID: 25447720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficiency of nested multiplex allele-specific PCR assay for detection of multidrug resistant tuberculosis directly from sputum samples.
    Mistri SK; Sultana M; Kamal SM; Alam MM; Irin F; Nessa J; Ahsan CR; Yasmin M
    Lett Appl Microbiol; 2016 May; 62(5):411-8. PubMed ID: 26972777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
    Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review.
    Kuupiel D; Vezi P; Bawontuo V; Osei E; Mashamba-Thompson TP
    BMC Infect Dis; 2020 Aug; 20(1):570. PubMed ID: 32758165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.
    Santos ADS; de Oliveira RD; Lemos EF; Lima F; Cohen T; Cords O; Martinez L; Gonçalves C; Ko A; Andrews JR; Croda J
    Clin Infect Dis; 2021 Mar; 72(5):771-777. PubMed ID: 32064514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test.
    Bodmer T; Ströhle A
    J Vis Exp; 2012 Apr; (62):e3547. PubMed ID: 22508485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.